Clinical Trial: Dual-Target Transcranial Magnetic Stimulation of the Orbitofrontal Cortex and Cerebellum for Improving Negative Symptoms of Schizophrenia: A Single-Arm, Open-Label Exploratory Study (China)

Posted On: 2026-08-12

China, Aug. 12 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Dual-Target Transcranial Magnetic Stimulation of the Orbitofrontal Cortex and Cerebellum for Improving Negative Symptoms of Schizophrenia: A Single-Arm, Open-Label Exploratory Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129836

Registration Time: 2026/08/11

Type: Interventional study

Primary Sponsor: Beijing An Ding Hospital, Capital Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337705

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Dual-Target Transcranial Magnetic Stimulation of the Orbitofrontal Cortex and Cerebellum for Improving Negative Symptoms of Schizophrenia: A Single-Arm, Open-Label Exploratory Study (China)